These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36262796)

  • 21. Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejection.
    Chance JJ; Segal JB; Wallerson G; Kasper E; Hruban RH; Kickler TS; Chan DW
    Clin Chim Acta; 2001 Oct; 312(1-2):31-9. PubMed ID: 11580907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrioventricular Block: A Heralding Sign of Cardiac Allograft Rejection.
    Shafaghi S; Naghashzadeh F; Sharif Kashani B; Behzadnia N; Ahmadi ZH
    Int J Organ Transplant Med; 2020; 11(2):90-92. PubMed ID: 32832044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of giant cell myocarditis in cardiac allograft.
    Scott RL; Ratliff NB; Starling RC; Young JB
    J Heart Lung Transplant; 2001 Mar; 20(3):375-80. PubMed ID: 11257566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care.
    Deng MC
    Expert Rev Precis Med Drug Dev; 2021; 6(1):51-63. PubMed ID: 33768160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection.
    Moran AM; Lipshultz SE; Rifai N; O'Brien P; Mooney H; Perry S; Perez-Atayde A; Lipsitz SR; Colan SD
    J Heart Lung Transplant; 2000 Aug; 19(8):756-64. PubMed ID: 10967269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased frequency of alloantigen-reactive helper T lymphocytes is associated with human cardiac allograft rejection.
    DeBruyne LA; Ensley RD; Olsen SL; Taylor DO; Carpenter BM; Holland C; Swanson S; Jones KW; Karwande SV; Renlund DG
    Transplantation; 1993 Sep; 56(3):722-7. PubMed ID: 8212173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging in Heart Transplant Patients.
    Olymbios M; Kwiecinski J; Berman DS; Kobashigawa JA
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1514-1530. PubMed ID: 30286911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review of Biomarkers of Cardiac Allograft Rejection: Toward an Integrated Diagnosis of Rejection.
    Coutance G; Desiré E; Duong Van Huyen JP
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitivity cardiac troponin I assay to screen for acute rejection in patients with heart transplant.
    Patel PC; Hill DA; Ayers CR; Lavingia B; Kaiser P; Dyer AK; Barnes AP; Thibodeau JT; Mishkin JD; Mammen PP; Markham DW; Stastny P; Ring WS; de Lemos JA; Drazner MH
    Circ Heart Fail; 2014 May; 7(3):463-9. PubMed ID: 24733367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study.
    Lim WH; Adams B; Alexander S; Bouts AHM; Claas F; Collins M; Cornelissen E; Dunckley H; de Jong H; D'Orsogna L; Francis A; Heidt S; Herman J; Holdsworth R; Kausman J; Khalid R; Kim JJ; Kim S; Knops N; Kosmoliaptsis V; Kramer C; Kuypers D; Larkins N; Palmer SC; Prestidge C; Prytula A; Sharma A; Shingde M; Taverniti A; Teixeira-Pinto A; Trnka P; Willis F; Wong D; Wong G
    BMC Nephrol; 2021 Dec; 22(1):416. PubMed ID: 34923958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management.
    Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A
    Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of sub-clinical acute cellular rejection after heart transplantation: comparison of cardiac magnetic resonance imaging and endomyocardial biopsy.
    Krieghoff C; Barten MJ; Hildebrand L; Grothoff M; Lehmkuhl L; Lücke C; Andres C; Nitzsche S; Riese F; Strüber M; Mohr FW; Gutberlet M
    Eur Radiol; 2014 Oct; 24(10):2360-71. PubMed ID: 24895035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome.
    Yamani MH; Haji SA; Starling RC; Tuzcu EM; Ratliff NB; Cook DJ; Abdo A; Crowe T; Secic M; McCarthy P; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):970-7. PubMed ID: 11897438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.
    Coutance G; Ouldamar S; Rouvier P; Saheb S; Suberbielle C; Bréchot N; Hariri S; Lebreton G; Leprince P; Varnous S
    J Heart Lung Transplant; 2015 Aug; 34(8):1050-7. PubMed ID: 25956740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial Fibrosis and Prognosis in Heart Transplant Recipients.
    Hughes A; Okasha O; Farzaneh-Far A; Kazmirczak F; Nijjar PS; Velangi P; Akçakaya M; Martin CM; Shenoy C
    Circ Cardiovasc Imaging; 2019 Oct; 12(10):e009060. PubMed ID: 31610691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure.
    Atluri P; Hiesinger W; Gorman RC; Pochettino A; Jessup M; Acker MA; Morris RJ; Woo YJ
    J Cardiothorac Surg; 2008 May; 3():26. PubMed ID: 18462494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T1 Mapping by Cardiac Magnetic Resonance and Multidimensional Speckle-Tracking Strain by Echocardiography for the Detection of Acute Cellular Rejection in Cardiac Allograft Recipients.
    Sade LE; Hazirolan T; Kozan H; Ozdemir H; Hayran M; Eroglu S; Pirat B; Sezgin A; Muderrisoglu H
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1601-1614. PubMed ID: 29680337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.